FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Mann Michael Scott 		2. Issuer Name and Ticker or Trading Symbol

ENDONOVO THERAPEUTICS, INC. [ ENDV ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      __ X __ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
President
(Last)          (First)          (Middle)

6320 CANOGA AVENUE 		3. Date of Earliest Transaction (MM/DD/YYYY)

4/5/2017
(Street)

WOODLAND HILLS, CA 91367
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

4/10/2017 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   4/5/2017   4/5/2017   P    1000   A $0.096   20059849   D    
Common Stock   4/5/2017   4/5/2017   P    1000   A $0.0899   20060849   D    
Common Stock   4/5/2017   4/5/2017   P    1000   A $0.0929   20061849   D    
Common Stock   4/5/2017   4/5/2017   P    1000   A $0.0925   20062849   D    
Common Stock   4/5/2017   4/5/2017   P    1000   A $0.089   20063849   D    
Common Stock   4/5/2017   4/5/2017   P    1000   A $0.0924   20064849   D    
Common Stock   4/5/2017   4/5/2017   P    1000   A $0.0923   20065849   D    
Common Stock   4/5/2017   4/5/2017   P    1000   A $0.0912   20066849   D    
Common Stock   4/6/2017   4/6/2017   P    1000   A $0.0737   20067849   D    
Common Stock   4/6/2017   4/6/2017   P    1000   A $0.074   20068849   D    
Common Stock   4/6/2017   4/6/2017   P    1000   A $0.077   20069849   D    
Common Stock   4/6/2017   4/6/2017   P    1000   A $0.078   20070849   D    
Common Stock   4/6/2017   4/6/2017   P    1000   A $0.079   20071849   D    
Common Stock   4/6/2017   4/6/2017   P    1000   A $0.0808   20072849   D    
Common Stock   4/6/2017   4/6/2017   P    1000   A $0.08   20073849   D    
Common Stock   4/6/2017   4/6/2017   P    1000   A $0.077   20074849   D    
Common Stock   4/6/2017   4/6/2017   P    1000   A $0.077   20075849   D    
Common Stock   4/6/2017   4/6/2017   P    1000   A $0.0799   20076849   D    
Common Stock   4/6/2017   4/6/2017   P    1000   A $0.081   20077849   D    
Common Stock   4/6/2017   4/6/2017   P    1000   A $0.0849   20078849   D    
Common Stock   4/6/2017   4/6/2017   P    1000   A $0.0848   20079849   D    
Common Stock   4/7/2017   4/7/2017   P    1000   A $0.086   20080849   D    
Common Stock   4/7/2017   4/7/2017   P    1000   A $0.087   20081849   D    
Common Stock   4/7/2017   4/7/2017   P    1000   A $0.087   20082849   D    
Common Stock   4/7/2017   4/7/2017   P    1000   A $0.087   20083849   D    
Common Stock   4/7/2017   4/7/2017   P    1000   A $0.0881   20084849   D    
Common Stock   4/7/2017   4/7/2017   P    1000   A $0.089   20085849   D    
Common Stock   4/7/2017   4/7/2017   P    1000   A $0.089   20086849   D    
Common Stock   4/7/2017   4/7/2017   P    1000   A $0.0881   20087849   D    
Common Stock   4/7/2017   4/7/2017   P    1000   A $0.089   20088849   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Mann Michael Scott
6320 CANOGA AVENUE
WOODLAND HILLS, CA 91367
X President

Signatures
Michael Mann 4/11/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.